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and T.E. Starzt 
NEW.ONSET diabetes mellitus as a complication fol-lowing transplantation has been prevIOusly reponed 
by several workers. ,-' However. the role of ethnicity as a 
factor has not been well defined. panicularly with the 
newer immunosuppressive agentsK~·D In an attempt to 
understand the nature of this problem In the African 
Amencan population. we retrospectively studied a group 
of African Americans who received renal allografts under 
FK 506 immunosuppression at the UniversIty of Pitts-
burgh Medica! Center between October 26. 1989. and July 
24. 1992. 
PATIENTS AND METHODS 
The study group consisted oi 41 adult African Americans (27 
maies and 14 females) who had undergone renai transplantation 
<>niy and receIved FK 506 immunosuppression from the time of 
transplantation. All patients had a minimum postopenlUve fol-
low-up of'" weeks. Blood glucose levels obtained preoperatively 
and during the first I:! weeks posuranspiantatlon were evaluated. 
Patients were classified as diabetic or nondiabetic as defined by 
Scantleburv et al.· Immunosuppression was With FK 506 and 
predmsone. although some patients m addition received azathio-
pnne. Stallsllcal analySIS for ooserved differences was done usmg 
the Fisher E;(act Test. Differences ot P <: .0.5 were conSidered 
"gJllficant. 
RESULTS 
There were tour identifiable groups within the first 11 
weeks after transplantauon: group I. normoglycemic pa-
lIents: group II. transIent hyperglycemIc. non-insulin-
dependent pallents: group III. perststent hyperglycemic. 
i nsulin·oependent (posttransplant diabetic) patients: and 
group IV. pretransplant diabetic patients. There were 39% 
116 of 41) in group I. 27% (II of 41) in group 11. 20% (8 of 
41) in group HI. and 15% (6 of 41) in group IV. Since 
uiabetes mellitus was already present preoperatively in 
group I V pauents. they were excluded from lunher anal-
VStS an the study. 
. In companson to the normoglycemlc patients (group fl. 
pauents who were hvpergiycemtc (groups 1I and lIl) 
tended to be older: 58% (II of 19) of patlcnts an groups 11 
.md III were over 40 years 01 age as opposed to 25% (4 of 
Ibl of the group i patients (p < .09). In addition. there was 
:l trend toward more patients undergoing retransplantauon 
In groups 11 and 1II-3i% (8 of 19). than an group 1-19% 
13 of 16) (P <: .(7). No difference was seen 10 the number 
01 patients who were hlghty sensitized (PRA > 40%). or an 
the cumulative steroId dose. 
DISCUSSION 
Although the occurrence of diabetes mellitus as a compli-
cation following transplantation has been previously de-
scribed.'..... the significance of ethnicity. if any. in its 
frequency of occurrence. has not been clearly estab-
lished. ~ Repons of a higher occurrence in African Ameri-
cans with no associated increase in morbidity has been 
reponedK~ but not conrirmed. The finding of 20% occur· 
rence in our study population is similar to other published 
series. gK~K~KT 
All our patients were on FK 506. a new investigational 
immunosuppressive agent. t>.1 Penubatlon of glucose me-
tabolism either by central inhibition of islet ceil insulin 
secretion or induction of penphera! insulin resistance. or a 
combination of both. in concen with the known diabeto-
genic innuences of steroids have been theorized as possi-
ble mechamsms of FK 506 diabetogemcllyK~·U Similar 
mechanisms have been put forward for cyclosponne as 
well. It has been our expenence that FK 506-induced 
diabetes mellitus IS reversible when the steroids and FK 
506 dosalZe are reduced. 7 
Our observation of an increased inCIdence of hypergly-
.;emia in the older population. had been noted by others.:-s 
and mav be a reriection of the general tendencv for 
diabetes to occur in the older popUlation. The finding at an 
increased Inctdence of hyperglycemia in patients receiving 
more than one allograft. although nO! stausllcally signtri-
.;ant. mav be Imponant and walT:lnlS lunher study. 
In conclusion. although the number of pallents In the 
study is small. the observed inCIdence or' posttransplant 
diabetcs mellitus. 20%. appears to be SImilar to that seen In 
other studies uSlOg a larger and more ethntcally heteroge-
neous transplant patient population. Theretore. ethnicity is 
probably not an Imponant tactor 10 the development of 
posttransplant diabetes mellitus. 
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